These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 23783559)
1. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes. Niranjan R Mol Neurobiol; 2014 Feb; 49(1):28-38. PubMed ID: 23783559 [TBL] [Abstract][Full Text] [Related]
2. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Enhances Activation of STAT3/NLRC4 Inflammasome Signaling Axis through PKCδ in Astrocytes: Implications for Parkinson's Disease. Samidurai M; Tarale P; Janarthanam C; Estrada CG; Gordon R; Zenitsky G; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A Cells; 2020 Aug; 9(8):. PubMed ID: 32759670 [TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease. Mosley RL; Benner EJ; Kadiu I; Thomas M; Boska MD; Hasan K; Laurie C; Gendelman HE Clin Neurosci Res; 2006 Dec; 6(5):261-281. PubMed ID: 18060039 [TBL] [Abstract][Full Text] [Related]
8. Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease. Collins LM; Toulouse A; Connor TJ; Nolan YM Neuropharmacology; 2012 Jun; 62(7):2154-68. PubMed ID: 22361232 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory response in Parkinson's disease (Review). Yan J; Fu Q; Cheng L; Zhai M; Wu W; Huang L; Du G Mol Med Rep; 2014 Nov; 10(5):2223-33. PubMed ID: 25215472 [TBL] [Abstract][Full Text] [Related]
10. Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes. Zeng Z; Roussakis AA; Lao-Kaim NP; Piccini P Neurobiol Aging; 2020 Nov; 95():264-270. PubMed ID: 32905922 [TBL] [Abstract][Full Text] [Related]
11. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death. Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425 [TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease. Taylor JM; Main BS; Crack PJ Neurochem Int; 2013 Apr; 62(5):803-19. PubMed ID: 23291248 [TBL] [Abstract][Full Text] [Related]
13. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease. Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705 [TBL] [Abstract][Full Text] [Related]
14. Aquaporin 4: A key player in Parkinson's disease. Tamtaji OR; Behnam M; Pourattar MA; Jafarpour H; Asemi Z J Cell Physiol; 2019 Dec; 234(12):21471-21478. PubMed ID: 31127615 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic Regulation of Neuroinflammation in Parkinson's Disease. Rasheed M; Liang J; Wang C; Deng Y; Chen Z Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066949 [TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. More SV; Kumar H; Kim IS; Song SY; Choi DK Mediators Inflamm; 2013; 2013():952375. PubMed ID: 23935251 [TBL] [Abstract][Full Text] [Related]
17. Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease. Tripathy D; Chakraborty J; Mohanakumar KP Free Radic Res; 2015; 49(9):1129-39. PubMed ID: 25968946 [TBL] [Abstract][Full Text] [Related]
18. Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation. Kempuraj D; Selvakumar GP; Thangavel R; Ahmed ME; Zaheer S; Kumar KK; Yelam A; Kaur H; Dubova I; Raikwar SP; Iyer SS; Zaheer A J Alzheimers Dis; 2018; 66(3):1117-1129. PubMed ID: 30372685 [TBL] [Abstract][Full Text] [Related]
19. Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB. Kempuraj D; Thangavel R; Selvakumar GP; Ahmed ME; Zaheer S; Raikwar SP; Zahoor H; Saeed D; Dubova I; Giler G; Herr S; Iyer SS; Zaheer A Mol Neurobiol; 2019 Mar; 56(3):1681-1693. PubMed ID: 29916143 [TBL] [Abstract][Full Text] [Related]
20. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation. Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]